Urteste S.A.
URT | WAR
Overview
Corporate Details
- ISIN(s):
- PLURTST00010 (+1 more)
- LEI:
- 259400Q4S6JIKFQHGU06
- Country:
- Poland
- Address:
- Gdańsk Starodworska 1, 80-137 Gdańsk
- Website:
- https://urteste.eu/en/home/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Urteste specialises in the development of an innovative technology allowing the detection of cancers at early stages of their development. The Urteste motto is: Early cancer detection saves lives. The company’s ground-breaking technology helps detect cancers by measuring the activity of the enzymes in urine. Urteste develops diagnostic tests for more than ten of the most common cancers. The company’s team consists of managers with wide experience in leading medical companies and scientists who specialise in the area of proteolytic enzymes and peptide chemistry.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-29 17:28 |
Quarterly Report
Raport kwartalny IQ2025
|
Polish | 1.7 MB | |
| 2025-05-28 15:17 |
Remuneration Report
Sprawozdanie o wynagrodzeniach - Raport Biegłego Rewidenta
|
Polish | 304.1 KB | |
| 2025-05-28 15:17 |
Remuneration Report
Sprawozdanie o wynagrodzeniach członków Zarządu i RN
|
Polish | 681.1 KB | |
| 2025-05-28 15:17 |
Corporate Governance Report
Sprawozdanie z działalności RN
|
Polish | 416.0 KB | |
| 2025-05-28 15:17 |
AGM Report
Projekty uchwał
|
Polish | 224.9 KB | |
| 2025-05-28 15:17 |
General Meeting Notice
Ogłoszenie o zwołaniu ZWZ na dzień 25.06.2025 r.
|
Polish | 199.5 KB | |
| 2025-05-28 15:17 |
General Meeting Notice
Zwołanie Zwyczajnego Walnego Zgromadzenia na dzień 25 czerwca 2025 roku - Conte…
|
Polish | 2.3 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Zarządu Urteste S.A.- firma audytorska
|
Polish | 21.1 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Zarządu Urteste S.A.- firma audytorska
|
Polish | 359.3 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Zarządu Urteste S.A.
|
Polish | 21.1 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Zarządu Urteste S.A.
|
Polish | 198.9 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Rady Nadzorczej Urteste S.A.- Komitet Audytu
|
Polish | 10.1 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Rady Nadzorczej Urteste S.A.- Komitet Audytu
|
Polish | 357.0 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Rady Nadzorczej Urteste S.A.
|
Polish | 10.1 KB | |
| 2025-04-29 18:04 |
Regulatory News Service
Oświadczenie Rady Nadzorczej Urteste S.A.
|
Polish | 391.8 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Herantis Pharma Oyj | Finland | HRTIS | |
| Hiron-Trade Investments & Industrial Buildings Ltd. | Israel | HRON | ||
|
Human Stem Cells Institute PJSC | Russian Federation | ISKJ | |
|
Human Xtensions Ltd. | Israel | HUMX | |
|
Hybrigenics SA | France | ALHYG | |
|
Hyloris Pharmaceuticals SA | Belgium | HYL | |
|
Ikonisys S.A. | France | ALIKO | |
|
IMCB PJSC | Russian Federation | GEMA | |
|
Inify Laboratories AB | Sweden | INIFY | |
|
Innate Pharma | France | IPH |